Bone Therapeutics is bringing a unique value proposition by developing a range of innovative bone cell therapy products administrable via a minimally invasive technique.
Our aim is to improve:
The company has developed a first-in-class products, ALLOB ® . The manufacturing process consists of the ex vivo culture of human bone marrow cells in order to generate human osteoblastic cells. All of Bone Therapeutics' products are manufactured to the highest GMP standards and all trials are designed in close consultation with the regulatory authorities. ALLOB is classified as advanced therapy medicinal products in Europe, renowned to have some of the strictest guidelines for the development of cell therapy products.